Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3679-3690
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3679
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3679
Table 3 Treatments
| n (%) | |
| Total | 18 (100) |
| Medical treatment | 11 (61.1) |
| Transit regulator | 4 (22.2) |
| Oral analgesic treatment | 1 (5.6) |
| Topical treatment | 8 (44.4) |
| Treatment of hemorrhoids | 4 (22.2) |
| 5-aminosalicylic acid | 1 (5.6) |
| Antibiotic (metronidazole) | 1 (5.6) |
| Botulinum toxin injection | 1 (5.6) |
| Healing cream | 1 (5.6) |
| Surgical treatment | 5 (27.9) |
| Electrocoagulation of condyloma | 1 (5.6) |
| Surgery of hemorrhoids | 2 (11.1) |
| Fissurectomy | 1 (5.6) |
| Posterior pelvectomy | 1 (5.6) |
| Instrumental and medical treatment | |
| Infrared coagulation and imiquimod | 1 (5.6) |
| Endoscopic treatment | |
| Hydraulic dilatation | 1 (5.6) |
- Citation: Moussaddaq AS, Brochard C, Palard-Novello X, Garin E, Wallenhorst T, Le Balc’h E, Merlini L’heritier A, Grainville T, Siproudhis L, Lièvre A. Incidental anal 18fluorodeoxyglucose uptake: Should we further examine the patient? World J Clin Cases 2020; 8(17): 3679-3690
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3679.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3679